Newsletter
Every new paper in this field, in your inbox.
The study describes 17 cases of post-ERCP cholecystitis out of 4428 patients undergoing ERCP (incidence 0.38%). Cover metal stenting resulted in a higher incidence of cholecystitis (1.50%). Symptoms appeared at a median of 5 days post-ERCP. Management strategies included cholecystectomy and endoscopic stent removal. These…
Utilizing the SMA-first approach in robotic pancreaticoduodenectomy (RPD) resulted in notable improvements in surgery for pancreatic cancer. The technique involved early dissection of the superior mesenteric artery (SMA) from the posterior aspect, facilitating a more systematic mesopancreatic dissection. The approach, demonstrated in a video, included…
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a leading cause of liver transplantations in western countries, with metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis, cirrhosis, and liver failure. Researchers anticipate the approval of the first drug for MASH by 2024, exploring pathways like thyroid…
Long-term surveillance of IPMNs led to early diagnosis and better outcomes of concomitant PDAC. Patients with IPMNs had higher rates of early cancer stage identification and R0 resection compared to those without IPMNs. Concomitant PDACs were associated with longer overall survival, with a 5-year survival…
Researchers analyzed 727 pancreatic cancer patients who received neoadjuvant therapy and pancreatectomy from 1998 to 2018. They found an increase in neoadjuvant chemotherapy use and a shift in the timing of recurrence risk from postoperative year 1 to year 2. Overall survival improved over time,…
Researchers explore the concept of biologic resectability in defining patient selection for metastasectomy in oligometastatic pancreatic ductal adenocarcinoma (PDAC). They assess safety and oncologic outcomes of metastasectomy in liver, peritoneum, and lung, and evaluate biomarkers like radiographic findings, biochemical markers (CA 19-9, CEA), and inflammatory…
Combining the Glissonean approach and indocyanine green fluorescence imaging aids in performing laparoscopic right anterior sectionectomy with precision, particularly in locating transection planes near the middle and right hepatic veins. In a case study, this technique enabled successful resection of a hepatocellular carcinoma with minimal…
Robotic and laparoscopic approaches to minimally invasive pancreatoduodenectomy yield similar oncologic and surgical outcomes in pancreatic cancer patients, with a lower conversion rate to open surgery for the robotic cohort. The learning curve has a significant impact on outcomes, with higher-volume centers showing improved results,…
Analysis of 817 patients after pancreaticoduodenectomy revealed that 19.5% developed postoperative pancreatic fistula (popf), with 45.9% being post-pancreatectomy acute pancreatitis (ppap)-associated popf. These patients had higher morbidity and distinct risk factors (blood loss, pancreatic texture) compared to non-ppap-associated popf. Non-ppap-associated popf was linked to age,…
Researchers compared robotic versus open hepatic arterial infusion pump placement for unresectable intrahepatic cholangiocarcinoma. The study found that robotic placement led to a significantly shorter time to functional recovery (2 versus 5 days) and hospital stay (3 versus 5 days) compared to open placement. Both…
